Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Nature

Volumn 449, Issue 7162, 2007, Pages 557-563

  Karnoub, Antoine E ^a   Dash, Ajeeta B ^b   Vo, Annie P ^a   Sullivan, Andrew ^b   Brooks, Mary W ^a   Bell, George W ^a   Richardson, Andrea L ^c   Polyak, Kornelia ^d   Tubo, Ross ^b   Weinberg, Robert A ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b GENZYME CORPORATION   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

CANCER; PHENOTYPE; PHYSIOLOGY; TUMOR;

ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; STROMA CELL; XENOGRAFT;

EID: 34948896045     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06188     Document Type: Article

References (36)

1. Bissell, M.J. & Radisky, D. Putting tumours in context. Nature Rev. Cancer 1, 46-54(2001).
2. Hall, B., Andreeff, M. & Marini, F. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb. Exp. Pharmacol. 180, 263-283 (2007).
3. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999).
4. Young, H. E. et al. Clonogenic analysis reveals reserve stem cells in postnatal mammals: I. Pluripotent mesenchymal stem cells. Anat. Rec. 263, 350-360 (2001).
5. Young, H. E. et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat. Rec. 264, 51-62 (2001).
6. Fox, J. M., Chamberlain, G., Ashton, B. A. & Middleton, J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br. J. Haematol. 137, 491-502 (2007).
7. Gregory, C. A., Prockop, D. J. & Spees, J. L. Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation. Exp. Cell Res. 306, 330-335 (2005).
8. Park, C.C., Bissell, M. J. & Barcellos-Hoff, M. H. The influence of the microenvironment on the malignant phenotype. Mol. Med. Today 6, 324-329 (2000).
9. Nakamura, K. et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 11, 1155-1164 (2004).
10. Nakamizo, A. et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65, 3307-3318 (2005).
11. Hung, S. C. et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 11, 7749-7756 (2005).
12. Menon, L. G. et al. Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25, 520-528 (2007).
13. Komarova, S., Kawakami, Y., Stoff-Khalili, M. A., Curiel, D. T. & Pereboeva, L. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol. Cancer Ther. 5, 755-766 (2006).
14. Khakoo, A. Y. et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 203, 1235-1247 (2006).
15. Studeny, M. et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res. 62, 3603-3608 (2002).
16. Luboshits, G. et al. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 59, 4681-4687 (1999).
17. Niwa, Y. et al. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin. Cancer Res. 7, 285-289 (2001).
18. Azenshtein, E. et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 62, 1093-1102 (2002).
19. Robinson, S. C. et al. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res. 63, 8360-8365 (2003).
20. Hillyer, P. & Male, D. Expression of chemokines on the surface of different human endothelia. Immunol. Cell Biol. 83, 375-382 (2005).
21. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).
22. Toker, A. & Yoeli-Lerner, M. Akt signaling and cancer: surviving but not moving on. Cancer Res. 66, 3963-3966 (2006).
23. Tanaka, T. et al. Chemokines in tumor progression and metastasis. Cancer Sci. 96, 317-322 (2005).
24. Mira, E. et al. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep. 2, 151-156 (2001).
25. Qin, X. F., An, D. S., Chen, I. S. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA 100, 183-188 (2003).
26. West, R. B. et al. Determination of stromal signatures in breast carcinoma. PLoS Biol. 3, e187 (2005).
27. Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32 (2004).
28. Balkwill, F. Cancer and the chemokine network. Nature Rev. Cancer 4, 540-550(2004).
29. Karnoub, A. E. & Weinberg, R. A. Chemokine networks and breast cancer metastasis. Breast Dis. 26, 75-85 (2006).
30. Palani, A. & Tagat, J. R. Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists. J. Med. Chem. 49, 2851-2857 (2006).
31. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005).
32. Elenbaas, B. et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15, 50-65 (2001).
33. Lodie, T. A. et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng. 8, 739-751 (2002).
34. Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999).
35. Kuperwasser, C. et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA 101, 4966-4971 (2004).
36. Richardson, A. L. et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132 (2006).